Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes.

Morris CR, Kuypers FA, Lavrisha L, Ansari M, Sweeters N, Stewart M, Gildengorin G, Neumayr L, Vichinsky EP.

Haematologica. 2013 Sep;98(9):1375-82. doi: 10.3324/haematol.2013.086637. Epub 2013 May 3.

2.

Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease.

Weiner DL, Hibberd PL, Betit P, Cooper AB, Botelho CA, Brugnara C.

JAMA. 2003 Mar 5;289(9):1136-42. Erratum in: JAMA. 2004 Aug 25;292(8):925.

PMID:
12622584
3.

Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.

Goldman RD, Mounstephen W, Kirby-Allen M, Friedman JN.

Pediatrics. 2013 Dec;132(6):e1634-41. doi: 10.1542/peds.2013-2065. Epub 2013 Nov 25.

4.

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.

Orringer EP, Casella JF, Ataga KI, Koshy M, Adams-Graves P, Luchtman-Jones L, Wun T, Watanabe M, Shafer F, Kutlar A, Abboud M, Steinberg M, Adler B, Swerdlow P, Terregino C, Saccente S, Files B, Ballas S, Brown R, Wojtowicz-Praga S, Grindel JM.

JAMA. 2001 Nov 7;286(17):2099-106.

PMID:
11694150
5.

Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.

Hardwick WE Jr, Givens TG, Monroe KW, King WD, Lawley D.

Pediatr Emerg Care. 1999 Jun;15(3):179-82.

PMID:
10389953
6.

Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.

Gladwin MT, Kato GJ, Weiner D, Onyekwere OC, Dampier C, Hsu L, Hagar RW, Howard T, Nuss R, Okam MM, Tremonti CK, Berman B, Villella A, Krishnamurti L, Lanzkron S, Castro O, Gordeuk VR, Coles WA, Peters-Lawrence M, Nichols J, Hall MK, Hildesheim M, Blackwelder WC, Baldassarre J, Casella JF; DeNOVO Investigators.

JAMA. 2011 Mar 2;305(9):893-902. doi: 10.1001/jama.2011.235.

7.

A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.

Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA; Pediatric Emergency Care Applied Research Network (PECARN).

Blood. 2015 Oct 1;126(14):1651-7. doi: 10.1182/blood-2015-05-647107. Epub 2015 Jul 31.

8.

Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.

Barrett MJ, Cronin J, Murphy A, McCoy S, Hayden J, an FhailĂ­ S, Grant T, Wakai A, McMahon C, Walsh S, O'Sullivan R.

Trials. 2012 May 30;13:74. doi: 10.1186/1745-6215-13-74.

9.

Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.

van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ.

Am J Hematol. 2007 Nov;82(11):955-60.

10.
11.

Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.

Buchanan ID, Woodward M, Reed GW.

Pediatr Blood Cancer. 2005 Oct 15;45(5):716-24.

PMID:
15926170
12.

Randomised trial of oral morphine for painful episodes of sickle-cell disease in children.

Jacobson SJ, Kopecky EA, Joshi P, Babul N.

Lancet. 1997 Nov 8;350(9088):1358-61.

PMID:
9365450
13.

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.

Heeney MM, Hoppe CC, Abboud MR, Inusa B, Kanter J, Ogutu B, Brown PB, Heath LE, Jakubowski JA, Zhou C, Zamoryakhin D, Agbenyega T, Colombatti R, Hassab HM, Nduba VN, Oyieko JN, Robitaille N, Segbefia CI, Rees DC; DOVE Investigators.

N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.

14.
15.

Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.

Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL.

Clin Trials. 2016 Aug;13(4):409-16. doi: 10.1177/1740774516636573. Epub 2016 Mar 21.

PMID:
27000103
16.

Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

Ballas SK, Bauserman RL, McCarthy WF, Castro OL, Smith WR, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

J Pain Symptom Manage. 2010 Dec;40(6):870-82. doi: 10.1016/j.jpainsymman.2010.03.020.

17.

RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: a pilot study.

Adams-Graves P, Kedar A, Koshy M, Steinberg M, Veith R, Ward D, Crawford R, Edwards S, Bustrack J, Emanuele M.

Blood. 1997 Sep 1;90(5):2041-6.

18.
19.

Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes.

Jacob E, Mueller BU.

Pain Med. 2008 Jan-Feb;9(1):13-21. doi: 10.1111/j.1526-4637.2006.00252.x.

PMID:
18254762
20.

Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.

Krishnamoorthy P, Alyaarubi S, Abish S, Gale M, Albuquerque P, Jabado N.

Pediatrics. 2006 Aug;118(2):e537-9.

PMID:
16882790

Supplemental Content

Support Center